Company Nutriband Inc Other OTC

Equities

US67092M1099

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Medical Equipment, Supplies & Distribution

Inactive Instrument

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. The Company's development pipeline includes AVERSA Buprenorphine and AVERSA Methylphenidate. The Company is also developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. Its AVERSA Fentanyl is an abuse-deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse-deterrent technology to reduce the abuse and misuse of fentanyl patches. It is also exploring transdermal delivery of proteins and peptides such as exenatide for type 2 diabetes and follicle-stimulating hormone (FSH) for infertility.

USD in Million	2023	Weight	2024	Weight	Delta
Pocono Pharmaceuticals 92.1 %	2	85.9 %	2	92.1 %	+7.54%
4P Therapeutics 7.9 %	0	14.1 %	0	7.9 %	-43.89%

USD in Million	2023	Weight	2024	Weight	Delta
United States 100.0 %	2	100.0 %	2	100.0 %	+0.27%

Managers	Title	Age	Since
Gareth Sheridan FOU	Founder	35	01/12/01
Serguei Melnik FOU	Founder	52	01/12/01
Gerald Goodman DFI	Director of Finance/CFO	76	31/18/31
Patrick Ryan CTO	Chief Tech/Sci/R&D Officer	38	01/18/01
Jeffrey Patrick CTO	Chief Tech/Sci/R&D Officer	55	15/18/15
Alan Smith COO	Chief Operating Officer	59	01/18/01
Larry Dillaha CTO	Chief Tech/Sci/R&D Officer	60	02/18/02
Tyler Overk PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Serguei Melnik FOU	Founder	52	01/12/01
Stefan Ciprian Mancas BRD	Director/Board Member	48	01/18/01
Gareth Sheridan FOU	Founder	35	01/12/01
Mark Hamilton BRD	Director/Board Member	39	01/18/01
Radu Bujoreanu BRD	Director/Board Member	53	14/19/14
Irina Gram-Contulescu BRD	Director/Board Member	36	21/22/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,979,870	6,869,367 ( 62.56 %)	10,000 ( 0.0911 %)	62.56 %

Name	Equities	%	Valuation
Gareth Sheridan 22.49 %	1,761,667	22.49 %	6 M $
T.I.I. - Jetservices Lda. (Zona Franca da Madeira) 17.20 %	1,347,524	17.20 %	5 M $
Serguei Melnik 10.47 %	820,418	10.47 %	3 M $
Vanguard Group, Inc. (Subfiler) 1.108 %	86,800	1.108 %	316 820 $
Geode Capital Management LLC 0.7477 %	58,571	0.7477 %	213 784 $
Alan Smith 0.6242 %	48,893	0.6242 %	178 459 $
Jeffrey Patrick 0.4674 %	36,612	0.4674 %	133 634 $
Gerald Goodman 0.3351 %	26,250	0.3351 %	95 813 $
STATE STREET CORPORATION 0.2204 %	17,266	0.2204 %	63 021 $
Mark Hamilton 0.2197 %	17,208	0.2197 %	62 809 $

Name	Equities	%	Valuation
Citadel Securities GP LLC -	25,119	-	19 467 $
Clear Street LLC -	3,380	-	2 620 $
UBS Securities LLC -	196	-	152 $

Nutriband, Inc.

121 South Orange Avenue Suite 1500

32801, Orlando

+407 377 6695

http://www.nutriband.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-5.11%	181B
MEDTRONIC PLC	+2.36%	112B
BECTON, DICKINSON AND COMPANY	-2.77%	67.92B
DEXCOM, INC.	+4.71%	50.1B
CENCORA, INC.	+8.08%	44.27B
HOYA CORPORATION	+9.39%	40.41B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.67%	31.95B
WEST PHARMACEUTICAL SERVICES, INC.	-0.25%	25.82B
TERUMO CORPORATION	+17.27%	25.29B

Other Medical Equipment, Supplies & Distribution